Your session is about to expire
← Back to Search
Liposomal Bupivacaine plus 0.25% Bupivacaine for Urological Diseases (Baby ORIOLES Trial)
Baby ORIOLES Trial Summary
This trial will test whether a long-acting painkiller can reduce pain and the need for narcotics in children after minor urology procedures.
- Urological Diseases
- Orchiectomy
- Hydrocele
- Hypospadias
- Cryptorchidism
- Chordee
Baby ORIOLES Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Baby ORIOLES Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there any more openings for participants in this research study?
"The clinical trial is still open for recruitment, as indicated by the information on clinicaltrials.gov. It was first published on October 1st 2021 and last modified on October 13th 2022."
How many volunteers are engaged in this clinical experiment?
"Affirmative. Information hosted by clinicaltrials.gov suggests that this medical trial, first posted on October 1st 2021, is actively recruiting patients. The target number of participants for the study is 200 at a single site."
What clinical indications is Exparel 133 MG Per 10 ML Injection typically prescribed for?
"Exparel 133 MG Per 10 ML Injection is a medication most commonly used to treat permphigus. Other clinical applications include the management of acute nonspecific tenosynovitis, general anesthesia, and lupus erythematosus cell."
What have been the reported adverse effects of Exparel 133 MG Per 10 ML Injection?
"Exparel 133 MG Per 10 ML Injection has been granted approval, thus receiving a rating of 3 on the safety scale."
Could you provide details on prior research done with Exparel 133 MG Per 10 ML Injection?
"At the present moment, there are 109 clinical trials examining Exparel 133 MG Per 10 ML Injection with 18 of those trials in their final stage. Philadelphia is one of many areas hosting these studies and 144 total locations have been identified as research sites."
Share this study with friends
Copy Link
Messenger